Aesthetic Medical International Holdings Group Limited, founded in Shenzhen, China in 1997, is an international listed group specialized in aesthetic medical services as well as the first aesthetic medical services organization listed in China's main board. AIH has always prioritized the safety and quality of aesthetic services, making it one of aesthetic services institutions with the best medical safety records as well as with the longest history in the industry and thus enjoying prestige in the society and among consumers.
Company profile
Ticker
AIH
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
SEC CIK
AIH stock data
Latest filings (excl ownership)
6-K
Current report (foreign)
19 Jan 23
6-K
Current report (foreign)
6 Dec 22
6-K
Aesthetic Medical International Reports Third Quarter 2022 Unaudited Financial Results
29 Nov 22
6-K
Current report (foreign)
8 Sep 22
6-K
Aesthetic Medical International Reports First Half of 2022 Unaudited Financial Results
17 Aug 22
6-K
Current report (foreign)
2 Aug 22
6-K
Current report (foreign)
20 Jul 22
6-K
Aesthetic Medical International Announced Closing of RMB100 Million Private Placement
14 Jul 22
6-K
Aesthetic Medical International Reports First Quarter 2022 Unaudited Financial Results
29 Jun 22
F-3
Shelf registration (foreign)
17 Jun 22
Latest ownership filings
SC 13D/A
Peak Asia Investment Holdings V Ltd
29 Jul 22
SC 13D
Hainan Oriental Jiechuang Investment Partnership (Limited Partnership)
29 Jul 22
SC 13D
Zhou Pengwu
29 Jul 22
SC 13D
Ding Wenting
29 Jul 22
SC 13D/A
Hainan Runming Biotechnology Co., Ltd.
14 Jul 22
SC 13D
Hainan Runming Biotechnology Co., Ltd.
10 Jun 22
SC 13G/A
IDG-Accel China Growth Fund III L.P.
28 Feb 22
SC 13G
IDG-Accel China Growth Fund III L.P.
28 Feb 22
SC 13G/A
Zhou Pengwu
24 May 21
SC 13D
Peak Asia Investment Holdings V Ltd
22 Sep 20
Financial summary
| Quarter (USD) | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
Institutional ownership, Q2 2022
| 13F holders | Current |
|---|---|
| Total holders | 9 |
| Opened positions | 1 |
| Closed positions | 3 |
| Increased positions | 1 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 294.08 mm |
| Total shares | 71.63 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Hainan Runming Biotechnology | 21.41 mm | $0.00 |
| Zhou Pengwu | 16.12 mm | $84.97 mm |
| Peak Asia Investment Holdings V | 15.58 mm | $100.00 mm |
| Ding Wenting | 15.49 mm | $99.45 mm |
| IDG-Accel China Growth Fund III | 2.38 mm | $8.27 mm |
| IDG Technology Venture Investment IV | 396.09 k | $844.00 k |
| JPM JPMorgan Chase & Co. | 156.53 k | $333.00 k |
| BCS Barclays | 84.75 k | $181.00 k |
| Renaissance Technologies | 13.30 k | $28.00 k |
| Proequities | 0.00 | $0.00 |
Press releases
Aesthetic Medical International Holdings Group Ltd. Received a Letter of Expected Delisting Determination From Nasdaq Staff and Requested a Hearing before the Nasdaq Hearings Panel
6 Dec 22
Aesthetic Medical International Reports Third Quarter 2022 Unaudited Financial Results
29 Nov 22
Aesthetic Medical International to Announce Third Quarter 2022 Unaudited Financial Results on November 29, 2022
22 Nov 22